(Q39403339)

11 September 2017

Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II. (English)

1 reference

11 September 2017

0 references

Eliseu Soares de Oliveira Rocha

Luiz Felipe Leomil Coelho

7

0 references

object named as

Luiz Felipe Leomil Coelho

10

0 references

Erna G. Kroon

object named as

Erna Geessien Kroon

8

0 references

author name string

Raissa Prado Rocha

1

1 reference

11 September 2017

Márcia Cristina Livonesi

2

1 reference

11 September 2017

Marcilio Jorge Fumagalli

3

1 reference

11 September 2017

Naiara Ferreira Rodrigues

4

1 reference

11 September 2017

Lauro César Felipe da Costa

5

1 reference

11 September 2017

Michelle Cristina Silva Gomes Dos Santos

6

1 reference

11 September 2017

Luiz Cosme Cotta Malaquias

9

1 reference

11 September 2017

21 April 2014

1 reference

11 September 2017

1 reference

11 September 2017

188

1 reference

11 September 2017

122-127

1 reference

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Domain III of the envelope protein as a dengue vaccine target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Controversies in dengue pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Global spread and persistence of dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Dengue virus pathogenesis: an integrated view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Immune response to dengue virus and prospects for a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Partial maturation: an immune-evasion strategy of dengue virus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Bovine serum albumin nanoparticle vaccine reduces lung pathology induced by live Pseudomonas aeruginosa infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.04.009

10.1016/J.VIRUSRES.2014.04.009

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference